Victoria Hendrick, MD

Management of Depression and Neurocognitive Impairment in Patients With HIV

January 15, 2023

Strategies for the evaluation and management of HIV-associated mood and cognitive changes and potential drug interactions between psychiatric and antiretroviral medications.

CARLAT WEBINAR

Frequently Overlooked Considerations in Women's Mental Health

January 10, 2023

Victoria Hendrick, MD

A summary of some of the current research findings in psychiatric treatment relating to women's mental health.

EXPERT Q&A

QT Intervals in Psychiatric Practice

October 1, 2022

Victoria Hendrick, MD and Paul Barkopoulos, MD.

Paul Barkopoulos, MD. Clinical Assistant Professor, Psychiatry & Biobehavioral Sciences, UCLA David Geffen School of Medicine and Olive View UCLA Medical Center, Los Angeles, CA.

Victoria Hendrick, MD. Editor-in-Chief, The Carlat Hospital Psychiatry Report; Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Dr. Barkopoulos and Dr. Hendrick, authors for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.

Several psychiatric medications prolong the QTc interval and place patients at risk of the dreaded torsade de pointes. Some patients are particularly vulnerable to QTc prolongation: the elderly, patients with heart disease and electrolyte imbalances, and patients taking certain medications, like thioridazine and ziprasidone. We provide a step-by-step guide so that you can keep your patients safe from this cardiovascular side effect.

Lithium Exposure In Utero—How Bad Is It Really?

July 1, 2022

Victoria Hendrick, MD and Lara Tang, MD

Lara Tang, MD, and Victoria Hendrick, MD. Dr. Tang and Dr. Hendrick have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We know prenatal lithium exposure increases the risk of heart defects in newborns. By keeping lithium doses and blood levels under certain cut-off points, we can reduce this risk, according to this large meta-analysis.

Victoria Hendrick, M.D., on Drug Interactions and Drug Side Effects Specific to Women

October 1, 2005

Victoria Hendrick, MD

Victoria Hendrick, M.D. Associate Professor of Psychiatry UCLA School of Medicine and Olive View-UCLA Medical Center Dr. Hendrick has disclosed that she was/is a member of the speakers bureaus for GlaxoSmithKline and Pfizer Pharmaceuticals, and has given talks on the reproductive safety of Paxil (GlaxoSmithKline) and Zoloft (Pfizer). Because of these industry relationships, the editors of The Carlat Report have edited the interview in order to resolve any possible faculty conflicts of interest regarding this educational activity.

Dr. Hendrick, thanks for your return visit to the pages of TCR! I’m wondering whether, as a specialist in the psychiatric treatment of women, you can tell us about particular drug interactions that you feel we should be more aware of in treating women.

Dr. Victoria Hendrick on Using Meds in Pregnancy

May 1, 2003

Victoria Hendrick, MD

Victoria Hendrick, M.D. Director of Pregnancy and Postpartum Mood Disorders Program Assistant Professor of Psychiatry and Biobehavioral Sciences University of California, Los Angeles

Dr. Hendrick, there has been a lot of confusing and seemingly contradictory data about the safety of SSRIs during pregnancy. What’s your take?